Self-Monitoring Blood Glucose Strips Market, by Product Type (Drop Blood Type Blood Glucose Strips, Siphon Type Blood Glucose Strips) and, by End User (Hospital, Clinics, Homecare): Global Opportunity Analysis and Industry Forecast, 2023-2032

Blood glucose monitoring devices are medical devices that are used to monitor blood glucose in diabetic patients or other glucose related diseases. Self-monitoring blood glucose strips are a type of blood glucose monitoring device that monitor blood glucose levels and aids in understanding ones diabetes control; it also informs changes to improve ones control. The major factor that drives the growth of this market is the increase in diabetic population globally.

In addition, the introduction of novel products such as test strips made from Indian silk and positive reimbursement of self-monitoring blood glucose devices in developed economies will also aid in the growth of this market. However, low awareness among healthcare professionals in developing economies will impede the market growth. In addition, self-monitoring blood glucose strips are mostly utilized in homes by general population, which is why chances of error increases that further restricts the growth of this market. Moreover, several technological advancements in untapped economies will result in more user friendly test strips with fewer complications, thereby creating more lucrative opportunities for this market.

The self-monitoring blood glucose strips market is segmented based on product type, end user, and geography. Based on product type this market is segmented into drop blood type blood glucose strips and siphon type blood glucose strips. Based on end user this market is segmented into hospitals, clinics, and homecare. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as LifeScan, Inc., Medtronic PLC, Roche Diagnostics, Abbott Laboratories, BD Medical, Beurer GmbH, MediWise Ltd., Menarini Diagnostics, Bioptik Technology, Pulsatom Healthcare and AgaMatrix, Inc. have also been provided in this report.

Key Benefits

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global self-monitoring blood glucose strips market.
• In-depth analysis has been carried out in this report by constructing market estimations for key market segments.
• Geographically, the global self-monitoring blood glucose strips market has been analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
• This study that evaluates the competitive landscape and value chain has been taken into account to help understand the competitive environment globally.
• Comprehensive analysis of factors that drive and restrict the growth of the global self-monitoring blood glucose strips market has been provided.
• This report provides the quantitative analysis of the current market and estimations, which assists in identifying prevailing market opportunities

  Self-Monitoring Blood Glucose Strips Market, by Product Type Report Highlights

Aspects	Details
By Product Type	Drop Blood Type Blood Glucose Strips Siphon Type Blood Glucose Strips
By End User	Hospital Clinics Homecare
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Turkey, Rest of LAMEA)
Key Market Players	LifeScan, Inc., AgaMatrix, Inc., Bioptik Technology, Beurer GmbH, Abbott Laboratories, Roche Diagnostics, Menarini Diagnostics, Pulsatom Healthcare, Medtronic PLC, BD Medical, MediWise Ltd.

^*Terms and Conditions Apply